The market study covers the United Arab Emirates Blood Screening Market crosswise segments. It purposes to estimate the market size and the growth prospective of the market segments, such as supplier, application, organization size, and business vertical. The study also includes a detailed competitive analysis of the key players in the market, along with their enterprise profiles, key observations related to product and industry offerings, new developments, and key market plans.

To Know More Request a Sample of this Report@ https://www.infiniumglobalresearch.com/united-arab-emirates/sample-request/43612

The United Arab Emirates (UAE) is experiencing a surge in demand for donated blood, propelled by the escalating need for complex surgical treatments. From cardiovascular and transplant surgeries to trauma care and therapy for cancer and blood-related illnesses, the imperative for adequate blood supplies has never been more crucial.

Globally, an average of 235 million major surgeries is performed annually, with 63 million attributed to trauma, over 31 million to cancer, and 10 million to pregnancy-related complications. Donated blood plays a pivotal role in preparing for diverse medical scenarios, including trauma, congenital maternal blood abnormalities in children, acute anemia, and complications during labor and delivery.

Recognizing the significance of timely and accessible blood transfusions, the UAE has embraced cutting-edge technologies to enhance the screening and detection processes. Digital immunoassays, utilizing a grid of femtoliter-sized wells in Enzyme-Linked Immunosorbent Assay (ELISA), present a breakthrough in single-molecule detection without the need for traditional washing procedures.

In these assays, a biomarker molecule, conjugated and amplified through an enzyme process, is introduced into a well alongside an antibody-coated magnetic microparticle. This revolutionary approach has garnered attention, particularly in the context of addressing the urgent need for serological COVID-19 antibody tests that are inexpensive, rapid, simple, highly sensitive, quantitative, and minimally invasive.

To address this pressing need, a rapid and incredibly sensitive immunoassay has been developed in the UAE, requiring only a droplet of serum in a single step. This pioneering technology aims to measure human serological IgG against SARS-CoV-2, providing a critical tool in the ongoing battle against the global pandemic.

As the UAE continues to play a pivotal role in advancing medical technologies and responding to evolving healthcare challenges, stakeholders are urged to collaborate and innovate in ensuring the availability of safe and efficient blood transfusion solutions.

Enquire Here Get Customization and Check a Discount for the Report @ https://www.infiniumglobalresearch.com/united-arab-emirates/customization/43612

Table of Contents

Chapter 1. Report Overview

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

Chapter 3. Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.2.4. Challenges

3.3. PEST-Analysis

3.4. Porter's Diamond Model for the United Arab Emirates Blood Screening Market

3.5. IGR-Growth Matrix Analysis

3.6. Competitive Landscape in the United Arab Emirates Blood Screening Market

Chapter 4. United Arab Emirates Blood Screening Market by Product Type

4.1. Reagents & Kits

4.2. Instruments

4.3. Software & Services

Chapter 5. United Arab Emirates Blood Screening Market by Technology

5.1. Nucleic Acid Amplification

5.2. ELISA

5.3. Rapid Tests

5.4. NGS

5.5. Western Bot Assay

Chapter 6. United Arab Emirates Blood Screening Market by End-user

6.1. Blood Banks

6.2. Hospitals

For More Insights on this report, Speak to Our Analyst @ https://www.infiniumglobalresearch.com/united-arab-emirates/enquiry/43612

Research Methodology:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the Blood Screening Market. Moreover, the study highlights current market trends and forecasts for 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period.